capsaicin has been researched along with Nervous System Disorders in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 6 (31.58) | 18.2507 |
2000's | 7 (36.84) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Bhandari, R; Gupta, R; Kuhad, A; Vashishth, A | 1 |
Cao, T; Tey, HL; Yosipovitch, G | 1 |
Fostini, AC; Rosen, JD; Yosipovitch, G | 1 |
Ahmad, M; Goucke, CR | 1 |
Esteky, H; Komaki, A | 1 |
Christoph, T; Erdmann, VA; Frank, R; Gillen, C; Grünweller, A; Kurreck, J; Mika, J; Schäfer, MK; Wade, EJ; Weihe, E | 1 |
Jang, JH; Kim, DW; Kim, KH; Lee, WT; Leem, JW; Nam, TS; Park, KA | 1 |
Althaus, M; Hanschmann, A; Klein, T; Magerl, W; Treede, RD | 1 |
Anogianaki, A; Caraffa, A; Castellani, ML; Cerulli, G; Conti, F; De Amicis, D; De Lutiis, MA; Frydas, S; Negrev, NN; Salini, V; Shaik, YB; Tete, S; Vecchiet, J | 1 |
Brown, MR; Buck, SH; Burks, TF; Davis, TP; Walsh, JH; Yamamura, HI | 1 |
Weidner, J | 1 |
Dux, M; Jancsó, G; Sann, H; Schemann, M | 1 |
Smith, PE; Wiles, CM | 1 |
Hautkappe, M; Jeffries, JA; Ostermeier, AM; Roizen, MF; Roth, S; Toledano, A | 1 |
Perfumi, M; Sparapassi, L | 1 |
Gebhart, GF; Maves, TJ; Meller, ST | 1 |
Kim, KH; Lee, SS; Sohn, YW; Yoo, ES | 1 |
Ohnishi, A | 1 |
6 review(s) available for capsaicin and Nervous System Disorders
Article | Year |
---|---|
Chronic Pruritus in the Geriatric Population.
Topics: Aged; Aged, 80 and over; Aging; Antidepressive Agents; Antipruritics; Calcineurin Inhibitors; Capsaicin; Cholestasis; Chronic Disease; Emollients; Histamine; Histamine Antagonists; Humans; Kidney Failure, Chronic; Liver Diseases; Menthol; Nervous System Diseases; Palliative Care; Paraneoplastic Syndromes; Pruritus; Skin Aging; Skin Diseases; Urticaria | 2018 |
Diagnosis and Management of Neuropathic Itch.
Topics: Adrenal Cortex Hormones; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antipruritics; Botulinum Toxins, Type A; Calcineurin Inhibitors; Capsaicin; Central Nervous System Diseases; Cognitive Behavioral Therapy; Histamine Antagonists; Humans; Nerve Block; Nervous System Diseases; Neurokinin-1 Receptor Antagonists; Pruritus | 2018 |
Management strategies for the treatment of neuropathic pain in the elderly.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Capsaicin; Cognitive Behavioral Therapy; Diabetic Neuropathies; Herpes Simplex; Humans; Lidocaine; Nerve Block; Nervous System Diseases; Neuralgia; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol | 2002 |
Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction.
Topics: Capsaicin; Humans; Nervous System Diseases; Pain; Skin Diseases | 1998 |
Drug treatment of neuropathic pain.
Topics: Aged; Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Humans; Mexiletine; Nervous System Diseases; Pain; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
[The spinal primary sensory neuron].
Topics: Adult; Aged; Animals; Capsaicin; Diabetic Neuropathies; Dysautonomia, Familial; Fabry Disease; Ganglia, Spinal; Humans; Male; Mercury Poisoning; Neoplasms; Nervous System Diseases; Neurons, Afferent; Rats; Rats, Inbred Strains; Sensation; Spinal Cord | 1988 |
1 trial(s) available for capsaicin and Nervous System Disorders
Article | Year |
---|---|
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Topics: Aminopyridines; Analgesics; Capsaicin; Cross-Over Studies; Cyclopentanes; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hyperalgesia; Injections, Intradermal; Nervous System Diseases; Pain; Physical Stimulation; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2008 |
12 other study(ies) available for capsaicin and Nervous System Disorders
Article | Year |
---|---|
Transient Receptor Potential Vanilloid 1 (TRPV1) as a plausible novel therapeutic target for treating neurological complications in ZikaVirus.
Topics: Calcium; Capsaicin; Humans; Infant, Newborn; Microcephaly; Nervous System Diseases; Neurons; TRPV Cation Channels; Zika Virus; Zika Virus Infection | 2021 |
Effects of neonatal C-fiber depletion on neocortical long-term potentiation and depression.
Topics: Animals; Animals, Newborn; Capsaicin; Electric Stimulation; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Neocortex; Nerve Fibers, Unmyelinated; Nervous System Diseases; Neural Pathways; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.
Topics: Animals; Base Sequence; Capsaicin; Chlorocebus aethiops; Colitis; COS Cells; Disease Models, Animal; Humans; Male; Mice; Molecular Sequence Data; Nervous System Diseases; Pain; Pyrazines; Pyridines; Rats; RNA Interference; Sequence Alignment; Sequence Homology, Amino Acid; TRPV Cation Channels | 2006 |
The role of uninjured C-afferents and injured afferents in the generation of mechanical hypersensitivity after partial peripheral nerve injury in the rat.
Topics: Analgesics, Non-Narcotic; Animals; Capsaicin; Ganglia, Spinal; Hyperalgesia; Ligation; Lumbosacral Region; Male; Nerve Fibers, Unmyelinated; Nervous System Diseases; Neural Conduction; Neurons, Afferent; Nociceptors; Rats; Rats, Sprague-Dawley; Rhizotomy; Sciatic Nerve; Spinal Nerves; Time Factors | 2007 |
Capsaicin an irritant anti-inflammatory compound.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Gastrointestinal Agents; Heart Diseases; Humans; Irritants; Nasal Decongestants; Neoplasms; Nervous System Diseases | 2007 |
Characterization of the peptide and sensory neurotoxic effects of capsaicin in the guinea pig.
Topics: Animals; Capsaicin; Cholecystokinin; Dose-Response Relationship, Drug; Ganglia, Spinal; Guinea Pigs; Morphine; Nerve Tissue Proteins; Nervous System Diseases; Neurons, Afferent; Nociceptors; Peripheral Nerves; Somatostatin; Spinal Cord; Substance P; Vasoactive Intestinal Peptide | 1983 |
Possible harmful effects from a capsaicin base aerosol dog repellent.
Topics: Aerosols; Animals; Capsaicin; Dog Diseases; Dogs; Fatty Acids, Unsaturated; Nervous System Diseases; Pesticides | 1980 |
Neurogenic inflammation in the gastrointestinal tract of the rat.
Topics: Animals; Blood Vessels; Capillary Permeability; Capsaicin; Enteritis; Gastritis; Intestines; Male; Nervous System Diseases; Rats; Rats, Wistar; Stomach | 1996 |
Cough responsiveness in neurogenic dysphagia.
Topics: Adult; Aged; Capsaicin; Case-Control Studies; Cough; Deglutition; Deglutition Disorders; Female; Humans; Male; Maximal Expiratory Flow Rate; Middle Aged; Nervous System Diseases; Pilot Projects; Sensory Thresholds; Vital Capacity | 1998 |
Rat offspring treated prenatally with capsaicin do not show some of the irreversible effects induced by neonatal treatment with neurotoxin.
Topics: Animals; Animals, Newborn; Body Weight; Capsaicin; Diuresis; Female; Maternal-Fetal Exchange; Nervous System Diseases; Neurotoxins; Pain Measurement; Pregnancy; Rats; Skin Diseases; Water | 1999 |
Neonatal capsaicin treatment prevents the development of the thermal hyperalgesia produced in a model of neuropathic pain in the rat.
Topics: Animals; Animals, Newborn; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Hot Temperature; Male; Nervous System Diseases; Pain; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 1992 |
Neurotoxicity and long lasting analgesia induced by capsaicinoids.
Topics: Analgesia; Animals; Benzoquinones; Capsaicin; Fluorescent Antibody Technique; Immunohistochemistry; Mice; Mice, Inbred ICR; Nerve Fibers; Nervous System Diseases; Radioimmunoassay; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1991 |